Guardian Pharmacy ServicesvsWalmart

GRDN and WMT stock compared: price, dividend, valuation and results, from SEC filings.

Guardian Pharmacy Services (GRDN) has a market value of $3.1B and Walmart (WMT) $1.02T. Over the last year, with dividends, GRDN moved +57.0% and WMT +24.9%. The P/E is 42.0 for GRDN and 46.3 for WMT. Dividend yield: GRDN none, WMT 0.77%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    GRDN$3.1B

    WMT$1.02T

    WMT is 325 times GRDN

  • Revenue, 12 months

    GRDN$1.5B

    WMT$736B

    WMT is 505 times GRDN

  • Net income, 12 months

    GRDN$75M

    WMT$22.1B

    WMT is 295 times GRDN

  • Operating margin

    GRDN6.5%

    WMT4.4%

    2.1 points apart

  • ROIC

    GRDN28.8%

    WMT17.8%

    11.0 points apart

  • P/E

    GRDN42.0

    WMT46.3

    WMT is 1.1 times GRDN

  • Dividend yield

    GRDN0.0%

    WMT0.8%

    0.8 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

GRDN+57.0%

WMT+24.9%

100120140160DecFebAprJunAugOct
Returns by period
PeriodGRDNWith dividendsWMTWith dividends
1 year since November 12, 2025+57.0%Price +57.0%+24.9%Price +23.8%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

GRDNGuardian Pharmacy ServicesWMTWalmart

Valuation

GRDNWMT
Valuation
Price$49.52$128.09
Market value$3.1B$1.02T
Enterprise value (EV)$3.0B$1.06T
P/E42.046.3
P/E, 5-year median–33.8
P/B11.210.4
EV/EBIT32.132.9
Free cash flow yield2.8%1.3%

Results and growth

GRDNWMT
Results and growth
Revenue, 12 months$1.5B$736B
Net income, 12 months$75M$22.1B
Free cash flow, 12 months$87M$13.5B
Earnings per share, 12 months$1.18$2.77
Revenue growth, year on year17.9%4.7%
Revenue growth a year, past+17.9%over 1 years+5.0%over 5 years
EPS growth a year, past–+11.5%over 5 years

Margins and returns on capital

GRDNWMT
Margins and returns on capital
Gross margin22.5%25.2%
Operating margin6.5%4.4%
Net margin5.1%3.0%
ROIC28.8%17.8%
ROE31.6%23.1%

Balance sheet

GRDNWMT
Balance sheet
Cash$120M$11.5B
Total debt$36M$70.3B
Net debt / EBITDA-1.00.9
Interest cover145.3×17.4×

Dividends and buybacks

GRDNWMT
Dividends and buybacks
Dividend yield–0.8%
Dividend per share, 12 months–$0.99
Dividend growth a year, past–+5.5%over 5 years
Buyback yield–0.8%
Shareholder yield–1.6%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: GRDN or WMT

Didn't find what you were looking for?

Ask us
Which is bigger, Guardian Pharmacy Services or Walmart?

By market value, Walmart ($1.02T) is about 325.5 times Guardian Pharmacy Services ($3.1B), at today's prices.

How did GRDN and WMT stock do over the last 1 years?

Since November 12, 2025, GRDN's price moved +57.0% and WMT's +23.8%. With dividends: GRDN +57.0% (+57.0% a year), WMT +24.9% (+24.9% a year). Past returns do not predict future ones.

Which pays the higher dividend, GRDN or WMT?

The dividend yield at today's price is none for Guardian Pharmacy Services and 0.77% for Walmart. Over the last twelve months they paid – and $0.99 per share.

What is the P/E of GRDN and WMT?

At today's price, the P/E is 42.0 for GRDN and 46.3 for WMT. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Guardian Pharmacy Services or Walmart?

Over the last twelve months, the net margin was 5.1% for Guardian Pharmacy Services and 3.0% for Walmart, and the operating margin 6.5% and 4.4%. Revenue was $1.5B and $736B.

Which is the better investment, Guardian Pharmacy Services or Walmart?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.